Smith & Nephew SNATS Debt to Equity Ratio 2010-2024 | SNN

Current and historical debt to equity ratio values for Smith & Nephew SNATS (SNN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Smith & Nephew SNATS debt/equity for the three months ending December 31, 2024 was 0.62.
Smith & Nephew SNATS Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $5.09B $5.27B 0.97
2024-06-30 $5.34B $5.21B 1.03
2023-12-31 $4.77B $5.22B 0.91
2023-06-30 $4.61B $5.23B 0.88
2022-12-31 $4.71B $5.26B 0.90
2022-06-30 $4.71B $5.40B 0.87
2021-12-31 $5.35B $5.57B 0.96
2021-06-30 $5.60B $5.33B 1.05
2020-12-31 $5.73B $5.28B 1.09
2020-06-30 $4.58B $4.96B 0.92
2019-12-31 $4.16B $5.14B 0.81
2019-06-30 $3.99B $4.95B 0.81
2018-12-31 $3.19B $4.87B 0.65
2018-06-30 $3.07B $4.64B 0.66
2017-12-31 $3.22B $4.64B 0.69
2017-06-30 $3.24B $4.20B 0.77
2016-12-31 $3.39B $3.96B 0.86
2015-12-31 $3.20B $3.97B 0.81
2015-06-30 $3.17B $4.05B 0.78
2014-12-31 $3.27B $4.04B 0.81
2014-09-30 $3.63B $4.02B 0.90
2014-06-30 $3.59B $4.16B 0.86
2014-03-31 $1.72B $4.22B 0.41
2013-12-31 $1.77B $4.05B 0.44
2013-09-30 $1.66B $3.91B 0.42
2013-06-30 $1.56B $3.90B 0.40
2013-03-31 $1.51B $3.95B 0.38
2012-12-31 $1.76B $3.88B 0.45
2012-09-30 $1.36B $3.64B 0.37
2012-06-30 $1.26B $3.56B 0.35
2012-03-31 $1.43B $3.45B 0.41
2011-12-31 $1.56B $3.19B 0.49
2011-09-30 $1.76B $3.06B 0.58
2011-06-30 $1.78B $3.13B 0.57
2011-03-31 $1.79B $3.00B 0.60
2010-12-31 $1.96B $2.77B 0.71
2010-09-30 $2.40B $2.48B 0.97
2010-06-30 $2.27B $2.31B 0.98
2010-03-31 $2.31B $2.23B 1.04
2009-12-31 $2.39B $2.18B 1.10
2009-09-30 $2.62B $2.01B 1.30
2009-06-30 $2.64B $1.88B 1.40
2009-03-31 $2.60B $1.71B 1.52
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $13.086B $5.810B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.094B 27.91
Boston Scientific (BSX) United States $148.004B 37.05
Stryker (SYK) United States $145.912B 30.51
EssilorLuxottica (ESLOY) France $130.051B 0.00
Medtronic (MDT) Ireland $112.158B 15.90
Lonza Group Ag (LZAGY) Switzerland $50.407B 0.00
Haleon (HLN) United Kingdom $48.971B 27.90
ResMed (RMD) United States $36.801B 27.64
Agilent Technologies (A) United States $33.162B 21.62
GE HealthCare Technologies (GEHC) United States $32.817B 15.58
Terumo (TRUMY) Japan $26.665B 34.63
Koninklijke Philips (PHG) Netherlands $22.070B 15.86
Insulet (PODD) United States $21.511B 84.44
Zimmer Biomet Holdings (ZBH) United States $18.366B 11.80
Baxter (BAX) United States $15.831B 11.82
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.138B 21.36
Lantheus Holdings (LNTH) United States $5.758B 14.52
Prestige Consumer Healthcare (PBH) United States $4.234B 18.91
Perrigo (PRGO) Ireland $3.598B 9.12
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.442B 15.68
ICU Medical (ICUI) United States $3.353B 24.73
Envista Holdings (NVST) United States $3.224B 26.79
GN Store Nord (GNNDY) Denmark $2.180B 18.06
QuidelOrtho (QDEL) United States $2.043B 14.05
LeMaitre Vascular (LMAT) United States $1.883B 42.08
AtriCure (ATRC) United States $1.692B 0.00
Acuren (TIC) United States $1.348B 0.00
Neogen (NEOG) United States $1.198B 15.33
AdaptHealth (AHCO) United States $1.190B 12.08
BioLife Solutions (BLFS) United States $1.132B 0.00
Kestra Medical Technologies (KMTS) United States $1.087B 0.00
Green Thumb Industries (GTBIF) United States $1.082B 24.33
Phibro Animal Health (PAHC) United States $0.982B 12.55
InMode (INMD) Israel $0.920B 9.27
CeriBell (CBLL) United States $0.644B 0.00
Evolus (EOLS) United States $0.622B 0.00
Owens & Minor (OMI) United States $0.613B 5.08
Capricor Therapeutics (CAPR) United States $0.611B 0.00
Curaleaf Holdings (CURLF) Canada $0.581B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Valneva SE (VALN) France $0.517B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.413B 0.00
VAREX IMAGING (VREX) United States $0.351B 12.91
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.327B 58.20
Canopy Growth (CGC) Canada $0.298B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.291B 0.00
Cerus (CERS) United States $0.281B 0.00
Viemed Healthcare (VMD) United States $0.272B 22.90
Cresco Labs (CRLBF) United States $0.263B 0.00
ZimVie (ZIMV) United States $0.261B 11.89
Sanara MedTech (SMTI) United States $0.258B 0.00
Sanuwave Health (SNWV) United States $0.258B 0.00
Omeros (OMER) United States $0.221B 0.00
Biote (BTMD) United States $0.215B 6.05
OraSure Technologies (OSUR) United States $0.214B 0.00
TriSalus Life Sciences (TLSI) United States $0.212B 0.00
Brainsway (BWAY) Israel $0.208B 55.05
Quanterix (QTRX) United States $0.196B 0.00
High Tide (HITI) Canada $0.191B 0.00
Utah Medical Products (UTMD) United States $0.185B 15.08
Organigram Global (OGI) Canada $0.185B 0.00
Verano Holdings (VRNOF) United States $0.184B 0.00
Exagen (XGN) United States $0.153B 0.00
FitLife Brands (FTLF) United States $0.133B 16.40
Vireo Growth (VREOF) United States $0.129B 0.00
Jin Medical (ZJYL) China $0.107B 0.00
MacroGenics (MGNX) United States $0.103B 0.00
Veru (VERU) United States $0.095B 0.00
Quipt Home Medical (QIPT) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.089B 11.50
TerrAscend (TSNDF) Canada $0.083B 0.00
Agape ATP (ATPC) $0.075B 0.00
InterCure (INCR) Israel $0.069B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Zynex (ZYXI) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Nephros (NEPH) United States $0.040B 54.43
United-Guardian (UG) United States $0.038B 13.25
Rockwell Medical (RMTI) United States $0.035B 0.00
Safety Shot (SHOT) United States $0.020B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00